Vanguard Group’s RAPT Therapeutics RAPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$7.04M Sell
880,049
-154,801
-15% -$1.24M ﹤0.01% 3084
2025
Q1
$10.1M Buy
1,034,850
+667,181
+181% +$6.51M ﹤0.01% 2840
2024
Q4
$4.65M Sell
367,669
-26,832
-7% -$339K ﹤0.01% 3302
2024
Q3
$6.34M Buy
394,501
+5,967
+2% +$95.9K ﹤0.01% 3168
2024
Q2
$9.48M Buy
388,534
+76,928
+25% +$1.88M ﹤0.01% 2964
2024
Q1
$22.4M Buy
311,606
+54,578
+21% +$3.92M ﹤0.01% 2547
2023
Q4
$51.1M Buy
257,028
+4,115
+2% +$818K ﹤0.01% 2181
2023
Q3
$33.6M Buy
252,913
+9,544
+4% +$1.27M ﹤0.01% 2318
2023
Q2
$36.4M Buy
243,369
+45,679
+23% +$6.83M ﹤0.01% 2332
2023
Q1
$29M Buy
197,690
+9,293
+5% +$1.36M ﹤0.01% 2430
2022
Q4
$29.8M Buy
188,397
+27,908
+17% +$4.42M ﹤0.01% 2431
2022
Q3
$30.9M Buy
160,489
+2,296
+1% +$442K ﹤0.01% 2420
2022
Q2
$23.1M Buy
158,193
+5,125
+3% +$748K ﹤0.01% 2571
2022
Q1
$26.9M Buy
153,068
+2,274
+2% +$400K ﹤0.01% 2616
2021
Q4
$44.3M Buy
150,794
+15,933
+12% +$4.68M ﹤0.01% 2419
2021
Q3
$33.5M Buy
134,861
+20,621
+18% +$5.12M ﹤0.01% 2585
2021
Q2
$29.1M Buy
114,240
+20,315
+22% +$5.17M ﹤0.01% 2643
2021
Q1
$16.7M Buy
93,925
+2,276
+2% +$404K ﹤0.01% 2881
2020
Q4
$14.5M Buy
91,649
+18,521
+25% +$2.93M ﹤0.01% 2801
2020
Q3
$18.8M Buy
73,128
+15,983
+28% +$4.12M ﹤0.01% 2487
2020
Q2
$13.3M Buy
57,145
+22,111
+63% +$5.13M ﹤0.01% 2626
2020
Q1
$5.96M Buy
35,034
+17,069
+95% +$2.9M ﹤0.01% 2891
2019
Q4
$3.97M Buy
+17,965
New +$3.97M ﹤0.01% 3244